Clinical evaluation of Venpulli (Vitiligo) in childre
Phase 2
Completed
- Conditions
- Health Condition 1: null- Babies with symptom of hypopigmented patches with hyperpigmented border without any structural changes in any part of the body
- Registration Number
- CTRI/2017/06/008755
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body.
2.Patients who are willing to stay in IPD Ward for atleast 10 days or willing to attend OP Dept. as required.
3.Patientâ??s informant / Parent willing to sign the informed consent stating that he/she will consciously stick to the treatment during 48 days but can opt out of the trial of his / her own conscious discretion.
4.Willing to cooperate for taking photographs whenever required with hisher consent.
Exclusion Criteria
1.Albinism
2.Dermatological aspect of Leprosy
3.Tinea versicolor
4.Burn scars
5.Dermatological aspect of Addisons diseases
6.Post inflammatory hypopigmentation
7.Pityriasis alba
8.Alopecia aerate
9.Chemical leucoderma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the trial drug measured by VASI Score.Timepoint: 1-48 days
- Secondary Outcome Measures
Name Time Method Occurrence of new lesion, anywhere else in the body after <br/ ><br>intake of trial medicineTimepoint: 3 months